Instadose Pharma Corp. (INSD)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 31, 2026, 9:30 AM EST
Market Cap532.00
Revenue (ttm)n/a
Net Income-360.92K
EPS-0.00
Shares Out531.93M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume345
Open0.0001
Previous Close0.0001
Day's Range0.0001 - 0.0001
52-Week Range0.000001 - 0.0001
Beta-838.82
RSI45.63
Earnings Daten/a

About Instadose Pharma

Instadose Pharma Corp. engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil. The company was founded in 2017 and is based in Burlington, Canada. [Read more]

Sector Healthcare
Founded 2017
Country United States
Stock Exchange OTCMKTS
Ticker Symbol INSD
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements

News

NOTICE For Investors In OTC: INSD: Update in Lawsuit against Instadose Pharma Corp. announced by Shareholders Foundation

San Diego, California--(Newsfile Corp. - December 6, 2022) - The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in shares of Instadose Pharma Co...

3 years ago - Newsfile Corp

Monday Deadline Reminder: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - February 25, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Instadose Pharma...

4 years ago - Newsfile Corp

7-Day Deadline Reminder: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - February 21, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Instadose Pharma...

4 years ago - Newsfile Corp

Investor Notice: Feb 28th Deadline for certain Investors in Instadose Pharma Corp. shares announced by Shareholders Foundation

SAN DIEGO, Feb. 16, 2022 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a deadline is coming up on February 28, 2022, in the lawsuit that was filed for certain investors in OTC: INSD...

4 years ago - PRNewsWire

Investor Action Notice: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - January 11, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Instadose Pharma ...

4 years ago - Newsfile Corp

The Law Offices of Frank R. Cruz Announces Investigation of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (INSD) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $INSD #investors--The Law Offices of Frank R. Cruz Announces Investigation of Instadose Pharma Corp. (INSD) on Behalf of Investors

4 years ago - Business Wire

Instadose Pharma Corp Ships 2.125 Metric Tons - Largest International Cannabis Delivery in History

Instadose Pharma Corp delivers 2.125 Metric Tons of Medicinal Cannabis from South Africa to North Macedonia in a historic international delivery, this record-breaking shipment represents the largest C...

4 years ago - PRNewsWire